Counter-Strike: GenOne vs NEW VISION (BO3) - CCT Europe Series #6 Group Stage

According to the latest prediction market data for the query “Counter-Strike: GenOne vs NEW VISION (BO3) - CCT Europe Series #6 Group Stage”, traders have formed a strong consensus.

Currently, Map 2 Winner is dominating the market with an overwhelming 7,150% chance of winning. O/U 2.5 Games follows in second place at 6,950%, while Match Winner sits in third with 5,300%. The betting volume for this specific market has already reached $170.1K, reflecting intense industry interest.

To better assess where each potential outcome stands, the market can be segmented into three distinct trading tiers based on implied probability and contract pricing:

🥇 Tier 1: The Dominant Leader

• Map 2 Winner (7,150%): Currently commanding the highest probability, Map 2 Winner is heavily favored by the order book. Traders looking to back this outcome face a “Buy Yes” contract price of 7,150¢, signaling a high degree of market conviction. This contract alone has generated $11.6K in volume.

🥈 Tier 2: The Primary Challengers

• O/U 2.5 Games (6,950%): Positioned as the most viable alternative, O/U 2.5 Games maintains a 6,950% chance of resolving true. Its “Buy Yes” shares currently trade at 6,950¢.
• Match Winner (5,300%): Sitting in third place with a 5,300% probability, the market shows measured skepticism toward Match Winner, treating it as an outside wildcard unless momentum shifts.

🥉 Tier 3: The Long-Tail Options (Combining for ~0%)

Beyond the top three choices, a wide field of macro variables and long-shot outcomes are being tracked. While their individual probabilities hover low, they represent crucial hedges for speculative traders:

• Alternative Options: This includes Map 2 Rounds Handicap: GenOne (-3.5) vs NEW VISION (+3.5) (5,000%), Map 2 Total Rounds: Over/Under 21.5 (5,000%), and Map 3 Rounds Handicap: GenOne (-3.5) vs NEW VISION (+3.5) (5,000%).
• Speculative Volume: Despite low statistical likelihood, certain long-tail contracts like Map 3 Total Rounds: Over/Under 21.5 are still attracting notable interest.

This market refers to the Counter-Strike Round 1 match between GenOne and NEW VISION in the CCT Europe Series #6 Group Stage, initially scheduled for July 28 at 10:00AM ET.

This market will resolve to "GenOne" if GenOne win the match against NEW VISION.

This market will resolve to "NEW VISION" if NEW VISION win the match against GenOne.

If the match is canceled (not played at all), ends in a tie, or is delayed beyond 7 days from the scheduled date without a winner determined, this market will resolve to 50-50.

If the match begins but is not completed, and one team wins due to the opponent's forfeiture, disqualification, or walkover, this market will resolve to the team who wins.

If the match ends in a forfeit, disqualification, or walkover (team withdraws before the start and the other wins automatically), this market will resolve to 50-50.

The resolution source for this market will be official information from https://hltv.org. However, if https://hltv.org has not published final results within 2 hours after the event’s conclusion, a consensus of credible reporting may be used instead including video evidence.

In cases where a team’s listed name includes minor discrepancies from the resolution source, this market will resolve based on the underlying real-world match rather than exact name matching. Recognizable abbreviations, alternate or erroneous spellings, sponsor tags, affiliate or academy designations, regional identifiers, and minor formatting differences will be treated as referring to the same team, provided the intended team can be clearly and uniquely identified within the relevant competition. If a listed team name has no reasonable connection to any participating team, or if it matches or could reasonably refer to another team in the same competition such that the intended team cannot be unambiguously determined, this market will resolve 50-50.